Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
WASHINGTON - The U.S. Food and Drug Administration has authorized Pfizer’s COVID-19 vaccine booster for 12- to 15-year-olds. The expanded approval is an important step in clearing the extra shots for ...
The U.S. Food and Drug Administration has approved emergency use authorization for a booster shot of the Pfizer-BioNTech vaccine to be given at least six months after completion of the second dose for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results